Plasma choline metabolites and colorectal cancer risk in the women's health initiative observational study

Cancer Research

Volumn 74, Issue 24, 2014, Pages 7442-7452

  Bae, Sajin ^a   Ulrich, Cornelia M ^b,c,d   Neuhouser, Marian L ^b   Malysheva, Olga ^a   Bailey, Lynn B ^e   Xiao, Liren ^b   Brown, Elissa C ^b   Cushing Haugen, Kara L ^b   Zheng, Yingye ^b   Cheng, Ting Yuan David ^b   Miller, Joshua W ^f,g   Green, Ralph ^g   Lane, Dorothy S ^h   Beresford, Shirley A A ^b   Caudill, Marie A ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

^f RUTGERS UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CHOLINE; CYANOCOBALAMIN; DIMETHYLGLYCINE; FOLIC ACID; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; TRIMETHYLAMINE OXIDE; TUMOR MARKER; METHYLAMINE; TRIMETHYLOXAMINE;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CHOLINE METABOLISM; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLISM; MICROBIOME; OBSERVATIONAL STUDY; PLASMA BETAINE CHOLINE RATIO; POSTMENOPAUSE; TUMOR LOCALIZATION; VITAMIN BLOOD LEVEL; BLOOD; COLORECTAL NEOPLASMS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; WOMEN'S HEALTH;

AGED; BETAINE; CHOLINE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; METHYLAMINES; MIDDLE AGED; RISK FACTORS; WOMEN'S HEALTH;

EID: 84918532090     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-1835     Document Type: Article

References (53)

1. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009;22:191-7.
2. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002;132:2413S-2418S.
3. Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med 2004;229:988-95.
4. Mason JB. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr 2003;133:941S-947S.
5. Caudill MA. Folate and choline interrelationships: metabolic and potential health implications. In:Bailey LB, editor. Folate in health and disease. Florida: CRC Press; 2009. p. 449-65.
6. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a reviewof molecular mechanisms and the evidence for folate's role. Adv Nutr 2012;3:21-38.
7. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132:2350S-2355S.
8. Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003;124:1240-8.
9. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511-9.
10. Brocker C, Thompson DC, Vasiliou V. The role of hyperosmotic stress in inflammation and disease. Biomol Concepts 2012;3:345-64.
11. Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, et al. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013;132:2648-58.
12. de Vogel S, Schneede J, Ueland PM, Vollset SE, Meyer K, Fredriksen A, et al. Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2011;20:1726-35.
13. Nitter M, Norga˚rd B, de Vogel S, Eussen SJPM, Meyer K, Ulvik A, et al. Plasma methionine, choline, betaine, and dimethylglycine, in relation to colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC). Ann Oncol 2014;25:1609-15.
14. Zeisel SH, daCosta KA, Youssef M, Hensey S. Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. J Nutr 1989;119:800-4.
15. Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 2005;106:357-87.
16. Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 2008;10:789-98.
17. Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 2009;20:743-52.
18. Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol 2013;34:1285-300.
19. US Food and Drug Administration, Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final Rule. 21 CFR Parts 136, 137, and 139. Fed Regist 1996;61:8781-97.
20. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
21. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13:S107-21.
22. Miller JW, Beresford SA, Neuhouser ML, Cheng TY, Song X, Brown EC, et al. Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr 2013;97:827-34.
23. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003;13:S122-8.
24. Yan J, Jiang X, West AA, Perry CA, Malysheva OV, Devapatla S, et al. Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans. Am J Clin Nutr 2012;95:1060-71.
25. Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O'Reilly DS. Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci 2003;792:333-43.
26. Gilfix BM, Blank DW, Rosenblatt DS. Novel reductant for determination of total plasma homocysteine. Clin Chem 1997;43:687-8.
27. Yan J, Winter LB, Burns-Whitmore B, Vermeylen F, Caudill MA. Plasma choline metabolites associate with metabolic stress among young overweight men in a genotype-specific manner. Nutr Diabetes 2012;2: e49.
28. Zschabitz S, Cheng TY, Neuhouser ML, Zheng Y, Ray RM, Miller JW, et al. B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr 2013;97:332-43.
29. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolismof human mammary epithelial cells. Cancer Res 1999;59:80-4.
30. Glunde K, Serkova NJ. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 2006;7:1109-23.
31. Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T, et al. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res 1999;90:419-24.
32. Glunde K, Bhujwalla ZM, Ronen SM. Choline metabolism in malignant transformation. Nat Rev Cancer 2011;11:835-48.
33. Yan J, Jiang X, West AA, Perry CA, Malysheva OV, Brenna JT, et al. Pregnancy alters choline dynamics: results of a randomized trial using stable isotope methodology in pregnant and nonpregnant women. Am J Clin Nutr 2013;98:1459-67.
34. Holtan SG, Creedon DJ, Haluska P, Markovic SN. Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 2009;84:985-1000.
35. Lin OS, Kozarek RA, Schembre DB, Ayub K, Gluck M, Drennan F, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA 2006;295:2357-65.
36. Zhang AQ, Mitchell SC, Smith RL. Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol 1999;37:515-20.
37. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19:576-85.
38. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 2006;103:12511-6.
39. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
40. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57-63.
41. Loscalzo J. Lipid metabolism by gut microbes and atherosclerosis. Circ Res 2011;109:127-9.
42. Kanazawa K, Konishi F, Mitsuoka T, Terada A, Itoh K, Narushima S, et al. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer 1996;77:1701-6.
43. Möller B, Hippe H, Gottschalk G. Degradation of various amine compounds by mesophilic clostridia. Arch Microbiol 1986;145:85-90.
44. Bäckhed F. Meat-metabolizing bacteria in atherosclerosis. Nat Med 2013;19:533-4.
45. Albert MJ, Mathan VI, Baker SJ. Vitamin B12 synthesis by human small intestinal bacteria. Nature 1980;283:781-2.
46. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 2013;24:160-8.
47. Giannella RA, Broitman SA, Zamcheck N. Vitamin B12 uptake by intestinal microorganisms: mechanism and relevance to syndromes of intestinal bacterial overgrowth. J Clin Invest 1971;50:1100-7.
48. Sherwood WC, Goldstein F, Haurani FI, Wirts CW. Studies of the smallintestinal bacterial flora and of intestinal absorption in pernicious anemia. Am J Dig Dis 1964;9:416-25.
49. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr 1999;19:357-77.
50. Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy. Drugs Aging 1998;12:277-92.
51. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
52. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 2008;68:329-37.
53. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82.